Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down – What’s Next?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $9.43, but opened at $8.76. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.79, with a volume of 923 shares traded.

Analysts Set New Price Targets

Several research firms recently weighed in on SGIOY. Jefferies Financial Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Finally, The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 1.5%

The firm has a market capitalization of $15.16 billion, a price-to-earnings ratio of 8.91, a PEG ratio of 3.45 and a beta of 0.08. The business’s 50-day moving average price is $8.80 and its 200 day moving average price is $9.88. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.58 and a quick ratio of 1.46.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $970.69 million. On average, equities analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.